Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Anti-acne Drugs
    • 1.2.1.2 Anti-aging Drugs
    • 1.2.1.3 Dermatitis Drugs
    • 1.2.1.4 Hair Loss Drugs
    • 1.2.1.5 Psoriasis Drugs
    • 1.2.1.6 Skin Cancer Drugs
    • 1.2.1.7 Melasma Drugs
    • 1.2.1.8 Seborrhea Drugs
  • 1.2.2 by Application
    • 1.2.2.1 Hospital Pharmacies
    • 1.2.2.2 Retail Pharmacies
    • 1.2.2.3 Online Pharmacies
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Anti-acne Drugs Market, 2013-2018
  • 4.1.2 Anti-aging Drugs Market, 2013-2018
  • 4.1.3 Dermatitis Drugs Market, 2013-2018
  • 4.1.4 Hair Loss Drugs Market, 2013-2018
  • 4.1.5 Psoriasis Drugs Market, 2013-2018
  • 4.1.6 Skin Cancer Drugs Market, 2013-2018
  • 4.1.7 Melasma Drugs Market, 2013-2018
  • 4.1.8 Seborrhea Drugs Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Anti-acne Drugs Market Forecast, 2019-2024
  • 4.2.2 Anti-aging Drugs Market Forecast, 2019-2024
  • 4.2.3 Dermatitis Drugs Market Forecast, 2019-2024
  • 4.2.4 Hair Loss Drugs Market Forecast, 2019-2024
  • 4.2.5 Psoriasis Drugs Market Forecast, 2019-2024
  • 4.2.6 Skin Cancer Drugs Market Forecast, 2019-2024
  • 4.2.7 Melasma Drugs Market Forecast, 2019-2024
  • 4.2.8 Seborrhea Drugs Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Hospital Pharmacies Market, 2013-2018
  • 5.1.2 Retail Pharmacies Market, 2013-2018
  • 5.1.3 Online Pharmacies Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Hospital Pharmacies Market Forecast, 2019-2024
  • 5.2.2 Retail Pharmacies Market Forecast, 2019-2024
  • 5.2.3 Online Pharmacies Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Johnson & Johnson
• 8.2 Merck
• 8.3 Bayer
• 8.4 Mylan Pharmaceuticals
• 8.5 Pfizer
• 8.6 F. Hoffmann-La Roche
• 8.7 Allergan
• 8.8 Valeant Pharmaceuticals
• 8.9 PharmaDerm Pharmaceuticals
• 8.10 Allergan Inamed Corporation

9 Conclusion

Summary
The global Prescription Dermatological Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Anti-acne Drugs 
Anti-aging Drugs 
Dermatitis Drugs 
Hair Loss Drugs 
Psoriasis Drugs 
Skin Cancer Drugs 
Melasma Drugs 
Seborrhea Drugs
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Johnson & Johnson 
Merck 
Bayer 
Mylan Pharmaceuticals 
Pfizer 
F. Hoffmann-La Roche 
Allergan 
Valeant Pharmaceuticals 
PharmaDerm Pharmaceuticals 
Allergan Inamed Corporation 
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital Pharmacies 
Retail Pharmacies 
Online Pharmacies
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa